FHLC Among Health Care ETFs
End-of-day Nov 16, 2026 · 27 Health care ETFs by 5Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.7% | −0.7% | +5.7% | +8.8% | +21.5% | +24.0% | +59.2% | +43.3% | +330.1% |
| Peer average | −1.5% | −3.2% | +4.0% | +1.6% | +19.6% | +25.3% | +73.9% | +24.7% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$146 of every $1,000 in FHLC is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 14.56% | $1,456.01 | 420K | $599.7M |
| 2 | JNJJohnson & Johnson | Healthcare | 8.70% | $869.74 | 1.3M | $358.2M |
| 3 | ABBVAbbvie | Healthcare | 6.63% | $662.97 | 927K | $273.1M |
| 4 | UNHUnitedhealth Group | Healthcare | 4.69% | $468.86 | 477K | $193.1M |
| 5 | MRKMerck & NEW | Healthcare | 4.63% | $462.52 | 1.3M | $190.5M |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.31% | $331.24 | 195K | $136.4M |
| 7 | AMGNAmgen | Healthcare | 3.21% | $321.24 | 283K | $132.3M |
| 8 | GILDGilead Sciences | Healthcare | 2.66% | $265.73 | 652K | $109.4M |
| 9 | ABTAbbott Laboratories | Healthcare | 2.38% | $238.07 | 914K | $98.1M |
| 10 | —Securities Lending CF | — | 2.19% | $219.42 | 90.4M | $90.4M |
| 11 | PFEPfizer | Healthcare | 2.09% | $209.40 | 3.0M | $86.2M |
| 12 | ISRGIntuitive Surgical | Healthcare | 1.99% | $198.54 | 186K | $81.8M |
| 13 | DHRDanaher | Healthcare | 1.88% | $188.45 | 334K | $77.6M |
| 14 | VRTXVertex Pharmaceuticals | Healthcare | 1.76% | $175.51 | 133K | $72.3M |
| 15 | 0Y6X.LMedtronic | Healthcare | 1.65% | $164.74 | 672K | $67.9M |
of the $113B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 14.56% |
| 2 | JNJ | Johnson & Johnson | 8.70% |
| 3 | ABBV | Abbvie | 6.63% |
| 4 | UNH | Unitedhealth Group | 4.69% |
| 5 | MRK | Merck & NEW | 4.63% |
| 6 | TMO | Thermo Fisher Scientific | 3.31% |
| 7 | AMGN | Amgen | 3.21% |
| 8 | GILD | Gilead Sciences | 2.66% |
| 9 | ABT | Abbott Laboratories | 2.38% |
| 10 | PFE | Pfizer | 2.09% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 18, 2026 | Sep 22, 2026 | $0.25 |
| Jun 18, 2026 | Jun 23, 2026 | $0.26 |
| Mar 20, 2026 | Mar 24, 2026 | $0.23 |
| Dec 19, 2025 | Dec 23, 2025 | $0.27 |
| Sep 19, 2025 | Sep 23, 2025 | $0.26 |
| Jun 20, 2025 | Jun 24, 2025 | $0.26 |
| Mar 21, 2025 | Mar 25, 2025 | $0.25 |
| Dec 20, 2024 | Dec 24, 2024 | $0.26 |
| Sep 20, 2024 | Sep 24, 2024 | $0.25 |
| Jun 21, 2024 | Jun 25, 2024 | $0.24 |
| Mar 15, 2024 | Mar 20, 2024 | $0.24 |
| Dec 15, 2023 | Dec 20, 2023 | $0.22 |